Related Experiment Video
Updated: Jun 22, 2026

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training
Published on: February 10, 2022
Pathways to approval of pediatric cardiac devices in the United States: challenges and solutions
Robert H Beekman1, Brian W Duncan, Donald J Hagler
1Division of Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. rbeekman@cchmc.org
Insights
Pediatric patients face unmet medical device needs. This review examines US Food and Drug Administration (FDA) processes and proposes alternate pathways for pediatric cardiac device approval.
Area of Science:
- Pediatric cardiology and cardiac surgery
- Medical device regulation
Background:
- Children often have unique medical device needs not met by current options.
- Existing regulatory pathways may not adequately address pediatric cardiac devices.
Purpose of the Study:
- To review current US Food and Drug Administration (FDA) regulatory processes for medical devices.
- To identify challenges in evaluating and approving cardiac devices for pediatric use.
- To discuss alternative regulatory pathways for pediatric cardiac devices.
Main Methods:
- Review of current US FDA regulatory guidelines.
- Analysis of unique aspects of pediatric cardiology and cardiac surgery.
- Discussion of potential alternative approval pathways.
Main Results:
- Current regulatory processes present challenges for pediatric cardiac devices.
- Specific aspects of pediatric cardiology and surgery complicate device evaluation.
- Alternative pathways may be necessary to facilitate device approval for children.
Conclusions:
- Children require specialized cardiac devices and technologies.
- The current regulatory framework needs adaptation to meet the needs of pediatric patients.
- Exploring alternate pathways is crucial for improving access to innovative cardiac devices for children.
Abstract:
Patients treated by pediatric interventional cardiologists and cardiac surgeons often have unmet medical device needs that pose a challenge to the current regulatory evaluation and approval process in the United States. In this report we review current US Food and Drug Administration regulatory processes, review some unique aspects of pediatric cardiology and cardiac surgery that pose challenges to these processes, and discuss possible alternate pathways to cardiac device evaluation and approval for children. Children deserve to benefit from new and refined cardiac devices and technology designed explicitly for their conditions.
More Related Videos
05:18Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
08:47Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
Published on: December 16, 2022
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Regulation
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution